Atea Pharmaceuticals Inc. (AVIR)

Atea Pharmaceuticals Inc. (AVIR) – FDA

Jan 8, 2024 04:05 PM Atea Pharmaceuticals (AVIR) Reports Positive Initial Data from Phase 2 Study for Hepatitis C Virus
Nov 13, 2023 07:04 AM Atea Pharmaceuticals (AVIR) Presents Promising Bemnifosbuvir and Ruzasvir Combination Data for the Treatment of Hepatitis C Virus
Apr 25, 2023 07:02 AM
Feb 23, 2023 07:00 AM
Nov 3, 2022 07:01 AM
Sep 26, 2022 07:01 AM
Sep 13, 2022 07:03 AM
Mar 28, 2022 07:09 AM
Jan 7, 2022 09:45 AM
Dec 14, 2021 04:32 PM
Nov 16, 2021 04:31 PM
Oct 19, 2021 07:02 AM
Aug 24, 2021 07:07 AM
Jun 17, 2021 11:13 AM
Apr 29, 2021 05:53 AM
Feb 19, 2021 08:32 AM
Feb 8, 2021 04:18 PM
Nov 29, 2017 07:03 AM
Feb 13, 2017 04:02 PM
Feb 1, 2017 04:32 PM
May 26, 2016 04:31 PM